C16 Biosciences, Inc.
Biotechnology company · New York, United States
C16 Biosciences, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2023.
C16 Biosciences at a glance
What does C16 Biosciences do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $5 million sold (2023).
Frequently asked questions about C16 Biosciences
Where is C16 Biosciences headquartered?
C16 Biosciences, Inc. is headquartered in New York, United States.
What does C16 Biosciences do?
C16 Biosciences, Inc. is a biotechnology company.
When was C16 Biosciences founded?
The earliest incorporation on record for C16 Biosciences, Inc. is in 2017, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences